Gland Pharma Acquires 100% Equity in Gland Pharma USA Inc.

Gland Pharma Limited announced that its Board of Directors has approved the acquisition of 100% of the equity share capital of Gland Pharma USA Inc. (Gland US) from Gland Pharma International Pte. Ltd. Upon completion, Gland US will become a direct wholly-owned subsidiary. This move aims to streamline the corporate structure by removing multiple layers, with no material impact expected on the company's business or operations. The transaction is a related party transaction conducted on an arm's length basis, with prior approval from the Audit Committee and the Board.